A retrospective analysis of efficacy and safety of adding bevacizumab to chemotherapy as first- and second-line therapy in advanced non-small-cell lung cancer (NSCLC)
Quan, Rencui, Huang, Jiaxing, Chen, Nan, Fang, Wenfeng, Hu, Zhihuang, Zhan, Jianhua, Zhou, Ting, Zhang, Li, Zhang, HongyuLanguage:
english
Journal:
Tumor Biology
DOI:
10.1007/s13277-016-5031-0
Date:
March, 2016
File:
PDF, 283 KB
english, 2016